Matthieu Leclerc Chalvet

Matthieu Leclerc Chalvet has been the CEO of Therapixel since June 2019. Prior to that, they were the Managing Director at Mirada Medical from July 2014 to June 2019. During their time at Mirada Medical, they were able to raise £6 million from Apposite Capital and return to double digit growth. Matthieu also established a strategic partnership with BTG plc. In May 2009, they became the VP Global Marketing Airway at Smiths Medical. During their time there, they were responsible for the Assisted Reproduction global business unit and led the commercial due diligence for an acquisition in emerging markets.

Matthieu Leclerc Chalvet has an Executive Programme in General Management from INSEAD, a Doctor of Philosophy (PhD) in Business, Marketing and Enterprise from the University of Hertfordshire, and an MSc in Biomedical Engineering from Université Claude Bernard Lyon 1.

Pierre Fillard - CSTO & Founder, Olivier Clatz - CPO, and Philippe-Anselme Foury - COO report to Matthieu Leclerc Chalvet.